Munich - Delayed Quote EUR

PerkinElmer Inc (PKN.MU)

79.70

0.00

(0.00%)

At close: May 23 at 8:00:15 AM GMT+2

RVTY Stock Falls Despite the Latest Launch of Automated Instrument

Revvity unveils IDS i20, a fully automated immunodiagnostics platform designed to enhance lab efficiency and expand specialty testing.

Zacks 2 days ago

RVTY

ITGR
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

StockStory 2 days ago

RVTY

MNRO

OMI
Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

WALTHAM, Mass., May 19, 2025--Revvity, Inc. (NYSE: RVTY), today announced the launch of its new IDS i20™ analytical random access platform from EUROIMMUN, enabling full automation of chemiluminescence immunoassays (ChLIA). The IDS i20 platform is a CE marked and FDA listed device that allows laboratories to consolidate multiple specialty tests on a unique single instrument with greater reagent capacity and higher test throughput compared to existing offerings.

Business Wire 6 days ago

RVTY
3 Mid-Cap Stocks with Questionable Fundamentals

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.

StockStory 10 days ago

COHR

RVTY

NVR
S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal

The S&P 500 ticked 0.1% higher on Wednesday, May 14, 2025, bolstered by a tech sector rally even as macroeconomic concerns pressured other sectors.

Investopedia 10 days ago

SMCI

^GSPC

TECH
Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings

Revvity, Inc. ( NYSE:RVTY ) just reported healthy earnings but the stock price didn't move much. Investors are probably...

Simply Wall St. 11 days ago

RVTY
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.

StockStory 12 days ago

BRKR

A

RGEN
RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine

Life sciences company Revvity (NYSE:RVTY) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.3% year on year to $664.8 million. The company’s full-year revenue guidance of $2.85 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $1.01 per share was 6.4% above analysts’ consensus estimates.

StockStory 13 days ago

RVTY
3 S&P 500 Stocks in the Doghouse

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

StockStory 19 days ago

WBA

^GSPC

SNA
1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

StockStory 24 days ago

RVTY

KMB

QNST
Revvity to Present at Upcoming Investor Conferences

WALTHAM, Mass., April 30, 2025--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:

Business Wire 25 days ago

RVTY
Mettler-Toledo (MTD) Q1 Earnings: What To Expect

Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market hours. Here’s what investors should know.

StockStory 25 days ago

MTD

RVTY
Revvity First Quarter 2025 Earnings: EPS Beats Expectations

Revvity ( NYSE:RVTY ) First Quarter 2025 Results Key Financial Results Revenue: US$664.8m (up 2.3% from 1Q 2024). Net...

Simply Wall St. 26 days ago

RVTY
Company News for Apr 29, 2025

Companies In The News Are: DPZ, RVTY, OPRA, INMD.

Zacks 26 days ago

RVTY

DPUKY
Revvity Inc (RVTY) Q1 2025 Earnings Call Highlights: Surpassing Expectations with Strong ...

Revvity Inc (RVTY) reports a robust Q1 2025 performance, exceeding EPS expectations and demonstrating resilience amidst macroeconomic challenges.

GuruFocus.com 26 days ago

RVTY
Q1 2025 Revvity Inc Earnings Call

Q1 2025 Revvity Inc Earnings Call

Thomson Reuters StreetEvents 26 days ago

RVTY
RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up

Revvity's first-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.

Zacks 26 days ago

RVTY
Biotech Firm Revvity Reports Better-Than-Expected Earnings

Revvity reported first-quarter earnings that topped analysts' estimates.

Investopedia 27 days ago

RVTY
Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Revvity (RVTY) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks 27 days ago

RVTY
Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook

(Reuters) -Medical equipment maker Revvity on Monday joined larger peers in warning about the impact of tariffs imposed by the U.S. President Donald Trump's administration, but maintained its annual profit outlook. Revvity anticipates a $135 million impact from tariffs on China; however, plans cost-saving measures and expects to benefit from a weaker dollar due to generating more than half its revenue outside the U.S. The warnings came after Revvity posted first-quarter results above Wall Street estimates on steady demand for tools used in medical research.

Reuters 27 days ago

RVTY

Performance Overview

Return	PKN.MU	S&P 500 (^GSPC)
YTD	-25.79%	-1.34%
1-Year	-23.01%	+10.16%
3-Year	-41.87%	+46.03%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

PerkinElmer Inc (PKN.MU)

RVTY Stock Falls Despite the Latest Launch of Automated Instrument

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

3 Mid-Cap Stocks with Questionable Fundamentals

S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal

Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine

3 S&P 500 Stocks in the Doghouse

1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid

Revvity to Present at Upcoming Investor Conferences

Mettler-Toledo (MTD) Q1 Earnings: What To Expect

Revvity First Quarter 2025 Earnings: EPS Beats Expectations

Company News for Apr 29, 2025

Revvity Inc (RVTY) Q1 2025 Earnings Call Highlights: Surpassing Expectations with Strong ...

Q1 2025 Revvity Inc Earnings Call

RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up

Biotech Firm Revvity Reports Better-Than-Expected Earnings

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook

Performance Overview